Search for Clinical Trial Results
Amyloidosis - 257 Studies Found
Status | Study |
Completed |
Study Name: DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis Condition: Familial Amyloidotic Cardiomyopathy (FAC) Date: 2014-09-22 |
Completed |
Study Name: Studying the Effect of Dialysate Temperature on Toxin Removal and Hypotension Condition:
Date: 2014-02-13 Interventions:
|
Recruiting |
Study Name: Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy Condition: Transthyretin (TTR) Amyloid Cardiomyopathy Date: 2016-06-01 Interventions: Drug: Tafamidis meglumine Soft gel capsules administered once a day for 60 months |
Active, not recruiting |
Study Name: Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy Condition: Transthyretin (TTR) Amyloid Cardiomyopathy Date: 2013-11-14 Interventions:
|
Completed |
Study Name: Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients Condition: Parkinson's Disease Date: 2009-03-05 Interventions: Drug: florbetapir F 18 10 millicurie (mCi) (370 MBq) florbetapir F 18 Injection |
Recruiting |
Study Name: Vinorelbine and Gemcitabine in Myeloma Condition:
Date: 2016-06-01 Interventions:
|
Active, not recruiting |
Study Name: CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2007-11-14 Interventions:
|
Completed |
Study Name: The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy Condition: Cardiomyopathy Date: 2008-06-06 Interventions: Drug: Fx-1006A Fx-1006A 20mg soft gelatin capsules once daily (at the same time each day) for 12 months |
Recruiting |
Study Name: Ixazomib Rollover Study Condition:
|
Completed |
Study Name: Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease Condition:
Date: 2014-08-13 Interventions: Other: [F18]-FDDNP radiopharmaceutical tracer, intravenous, single dose, of 360+/- 20 megabecquerel |